728918-75-0

Basic information

• Product Name: 4-(2,4-Difluorophenyl)benzaldehyde
• Synonyms: 4-(2,4-Difluorophenyl)benzaldehyde;4-(2,5-Difluorophenyl)benzaldehyde;4-(2,6-Difluorophenyl)benzaldehyde
• CAS NO: 728918-75-0
• Molecular Formula: C₁₃H₈F₂O
• Molecular Weight: 218.2
• Mol File: 728918-75-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(2,4-Difluorophenyl)benzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2,4-Difluorophenyl)benzaldehyde(728918-75-0)
• EPA Substance Registry System: 4-(2,4-Difluorophenyl)benzaldehyde(728918-75-0)

Safety Data

• Hazardous Substances Data: 728918-75-0(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
4-(2,4-Difluorophenyl)benzaldehyde is used as a building block in the creation of other complex organic molecules, particularly in the production of pharmaceuticals and agrochemicals. Its unique structure and properties make it of interest in scientific research and development.
Used in Pharmaceutical Industry:
4-(2,4-Difluorophenyl)benzaldehyde is used as an intermediate in the synthesis of various pharmaceutical compounds. Its presence of two fluorine atoms on the phenyl ring can enhance the biological activity and selectivity of the resulting drugs.
Used in Agrochemical Industry:
4-(2,4-Difluorophenyl)benzaldehyde is used as a precursor in the development of agrochemicals, such as pesticides and herbicides. Its unique structure can contribute to the effectiveness and selectivity of these products in controlling pests and weeds.

Upstream product

• 1122-91-4 4-bromo-benzaldehyde 
• 144025-03-6 2,4-difluorophenylboronic acid 

Downstream Products

• 104941-35-7 (-)-4-(2',4'-difluoro-[1,1'-biphenyl]-4-yl)-2-methyl-4-oxobutanoic acid 
• 104941-35-7 (R)-(+)-4-(2',4'-difluoro-[1,1'-biphenyl]-4-yl)-2-methyl-4-oxobutanoic acid 
• 1049800-49-8 (E)-2-(1-((2',4'-difluorobiphenyl-4-yl)methylene)-5-fluoro-1H-inden-3-yl)ethanoic acid 

Relevant articles and documents

Syntheses of a flobufen metabolite and dapoxetine based on enantioselective allylation of aromatic aldehydes

The enantioselective allylation of an aromatic aldehyde to give a chiral homoallylic alcohol was employed as the key step in the syntheses of a flobufen metabolite and dapoxetine. In the former case, the homoallylic alcohol moiety (99 % ee) was converted into a five-membered lactone ring with good preservation of the optical purity, and the target compound, a flobufen metabolite, was obtained in 95 % ee. In the latter case, the homoallylic alcohol moiety (97 % ee) was transformed over several steps into a 3-aminopropanol moiety. During the course of the synthesis, the gradual loss of optical purity was observed, and the target compound, dapoxetine, was obtained in 85 % ee. The enantioselective allylation of an aromatic aldehyde to give the corresponding homoallylic alcohol was the key step in the syntheses of a flobufen metabolite and dapoxetine. In the first case, the homoallylic moiety was converted into a chiral five-membered lactone ring. In the second case, it was transformed into a chiral 1,3-amino alcohol moiety. Copyright

ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS

This disclosure relates to compositions and methods including for the inhibition, prevention, and/or treatment of microbial infections, including infections from such pathogens as Staphylococcus aureus.

Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in staphylococcus aureus

Staphylococcus aureus produces a golden carotenoid virulence factor called staphyloxanthin (STX), and we report here the inhibition of the enzyme, dehydrosqualene synthase (CrtM), responsible for the first committed step in STX biosynthesis. The most acti

Pyrimidinone compounds

Pyrimidinone compounds of formula (I) are inhibitors of the enzyme Lp-PLA2 and of use in therapy, in particular for treating atherosclerosis.